NCT02147054View on ClinicalTrials.gov

A Pilot Study Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Organophosphate Poisoning
Interventions
DRUG

Rocuronium

DRUG

Sugammadex

Effect of Rocuronium will be reversed at the appropriate time using Sugammadex 16mg/kg as a single dose which may be repeated once.

Trial Locations (1)

Unknown

Peradeniya Teaching Hospital, Peradeniya

All Listed Sponsors
collaborator

University of Peradeniya

OTHER

lead

University of Edinburgh

OTHER

NCT02147054 - A Pilot Study Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning | Biotech Hunter | Biotech Hunter